since these results indicated that optimal breast tumor toxicity in vitro was achieved by 18- to 24-hr sequencing of methotrexate and 5-fluorouracil , clinical toxicity study was carried out to assess whether this drug schedule could be tolerated .
C1458155
breast tumor
C0016360
5-fluorouracil